Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Acumen Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ABOS
Nasdaq
2834
acumenpharm.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals: 3 Key Takeaways for Long-Term Investors
- Nov 4th, 2026 7:08 pm
BC-Most Active Stocks
- Oct 30th, 2026 8:30 am
Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint
- Oct 30th, 2026 5:00 am
Acumen Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
- Oct 26th, 2026 10:42 am
Acumen Pharmaceuticals (ABOS) Q3 2026 Earnings Call Transcript
- Oct 26th, 2026 10:12 am
Acumen Pharmaceuticals Reports Smaller Q3 Loss, Shares Rise as Phase 2 Alzheimer’s Data Approach
- Oct 26th, 2026 8:09 am
Acumen Pharmaceuticals Q3 Earnings Call Highlights
- Oct 26th, 2026 8:02 am
Acumen Pharmaceuticals beats Q3 estimates, shares jump 6%
- Oct 26th, 2026 6:07 am
Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlights
- Oct 26th, 2026 5:00 am
Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
- Oct 22nd, 2026 5:30 am
Acumen Pharmaceuticals to Report Third Quarter Financial Results on October 26, 2026
- Oct 19th, 2026 2:00 pm
4 Alzheimer's Drug Stocks to Watch on World Alzheimer's Day
- Sep 21st, 2026 10:40 am
Acumen Pharmaceuticals to Hold Virtual Investor Day on September 16, 2026
- Sep 10th, 2026 2:00 pm
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences
- Sep 2nd, 2026 2:00 pm
Acumen Pharmaceuticals Inc (ABOS) (Q2 2026) Earnings Call Highlights: Advancing Sabirnetug ...
- Aug 12th, 2026 5:04 pm
Acumen Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
- Aug 12th, 2026 10:56 am
Acumen Pharmaceuticals Q2 Earnings Call Highlights
- Aug 12th, 2026 7:03 am
Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
- Aug 12th, 2026 5:00 am
Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026
- Aug 5th, 2026 2:00 pm
Scroll